Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Clinical Oncology

• Publication date

  2012-07-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2011.40.2792PMID 22665539PMCID PMC4559602
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables.

  2011influential reference
• A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).

  2009cited by this paper
• Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

  2008cited by this paper
• Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

  2006influential reference
• Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

  2006cited by this paper
• Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Oxaliplatin, Cisplatin, and Carboplatin in Nonhuman Primates

  2005cited by this paper
• Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.

  2005cited by this paper
• Histopathologic grading of medulloblastomas

  2002cited by this paper
• Medulloblastomas With Favorable Versus Unfavorable Histology: How Many Small Blue Cell Tumor Types are There in the Brain?: On: Histopathologic grading of medulloblastomas. A pediatric oncology group study. Eberhart CG, Kepner JL, Goldthwaite PT, et al. Cancer 200294:552–560

  2002cited by this paper
• Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

  2000cited by this paper
• “Large Cell/Anaplastic” Medulloblastomas: A Pediatric Oncology Group Study

  2000cited by this paper
• Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

  1999cited by this paper
• Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks.

  1995cited by this paper
• Enhanced radiation-induced cell killing by carboplatin in cells of repair-proficient and repair-deficient cell lines.

  1995cited by this paper
• Irradiation enhances cellular uptake of carboplatin.

  1995cited by this paper
• Carboplatin in childhood medulloblastoma/PNET: feasibility of an in vivo sensitivity test in an "up-front" study.

  1995cited by this paper
• Metastatic medulloblastoma: the experience of the French Cooperative M7 Group.

  1994cited by this paper
• Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

  1994cited by this paper
• Carboplatin in childhood brain tumors: A children's cancer study group phase II trial

  1990cited by this paper
• Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.

  1982cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper

• Trends in childhood cancer: Incidence and survival analysis over 45 years of SEER data

  2025cites this paper
• Challenges and opportunities for treatment of medulloblastoma.

  2025cites this paper
• Reduced versus standard dose craniospinal irradiation with chemotherapy to treat medulloblastoma

  2025cites this paper
• Prognostic value of temporal muscle thickness in pediatric medulloblastoma patients aged 3–12 years

  2025cites this paper
• MULTICENTRE EVALUATION OF THE MANAGEMENT OF CHILDREN WITH HIGH RISK MEDULLOBLASTOMA: REAL WORLD PERFORMANCE OF THE SJMB03 AND COG-99701 PROTOCOLS

  2025cites this paper
• Old Tools in a New Era: The Continued Relevance of Chemotherapy in Pediatric Neuro-Oncology

  2025cites this paper
• Systematic Review and Meta-Analysis of Proton Beam Therapy Versus Photon Radiotherapy for Medulloblastoma: TRP-Medulloblastoma 2025

  2025cites this paper
• Medulloblastoma in Adolescents and Young Adults (AYA): Bridging Pediatric Paradigms and Adult Oncology Practice

  2025cites this paper
• Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a PDGFRA inhibitor trial

  2025influential citation
• Meningioma and Cerebral Spindle Cell Sarcoma as Two Different Metachronous Tumor Entities Secondary to Medulloblastoma Treatment in Childhood: Case Report and Review of the Literature

  2025cites this paper
• Feasibility and Outcomes of Craniospinal Irradiation and Concurrent Daily Carboplatin in Children and Adults With High-risk Central Nervous System Tumours.

  2025cites this paper
• Adult tentorial medulloblastoma mimicking meningioma: A case report and systematic review

  2025cites this paper
• Advancing medulloblastoma therapy: strategies and survival insights

  2025cites this paper
• Impact of radiation response on survival in pediatric medulloblastoma with residual or disseminated disease

  2025cites this paper
• Application of Radiomics in Predicting the Prognosis of Medulloblastoma in Children

  2025cites this paper
• Pediatric CNS tumors: Overview and treatment paradigms.

  2025cites this paper
• Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.

  2025cites this paper
• Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data

  2025cites this paper
• Risk factors and risk prediction model for recurrence in medulloblastoma

  2025cites this paper
• Medulloblastoma Molecular Subgrouping and Outcomes Data of a Single Center From a Low‐ and Middle‐Income Country

  2025cites this paper
• A Simple and Scalable Zebrafish Model of Sonic Hedgehog Medulloblastoma

  2024cites this paper
• The impact of nutritional status on treatment-related toxicities in children with embryonal brain tumors: The need for proactive nutritional management.

  2024cites this paper
• Medulloblastoma therapy: Consensus treatment recommendations from SIOP-Europe and the European Research Network

  2024cites this paper
• Exploiting Integrin-αVβ3 to Enhance Radiotherapy Efficacy in Medulloblastoma via Ferroptosis

  2024cites this paper
• Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma

  2024cites this paper
• A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma

  2024cites this paper
• Mechanistic insights into medulloblastoma relapse.

  2024cites this paper
• Impact of treatment and clinical characteristics on the survival of children with medulloblastoma in Mexico

  2024cites this paper
• miR-124-3p and miR-194-5p regulation of the PI3K/AKT pathway via ROR2 in medulloblastoma progression

  2024cites this paper
• GD2-Targeting CAR T-cell Therapy for Patients with GD2+ Medulloblastoma

  2024cites this paper
• Maintaining Survival While Improving Quality of Life: An Advanced Practitioner–Led Pilot Feasibility Study to Reduce Radiation Dose in Children With Brain Tumors

  2024influential citation
• FANCD2 deficiency sensitizes SHH medulloblastoma to radiotherapy via ferroptosis

  2024influential citation
• Cortical laminar necrosis mimicking leptomeningeal recurrence in a child with medulloblastoma and epilepsy

  2023cites this paper
• Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches

  2023cites this paper
• Evolution of neurosurgical advances and nuances in medulloblastoma therapy

  2023cites this paper
• Successful Implementation of Image-Guided Pencil-Beam Scanning Proton Therapy in Medulloblastomas

  2023cites this paper
• Posterior fossa tumors in children: current insights

  2023cites this paper
• Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors

  2023cites this paper
• Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center

  2023cites this paper
• Functional characterization of acid-sensing ion channels in the cerebellum-originating medulloblastoma cell line DAOY and in cerebellar granule neurons

  2023cites this paper
• Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review

  2023cites this paper
• Pediatric Brain Tumours: Lessons from the Immune Microenvironment

  2023cites this paper
• Epigenetics and immune cells in medulloblastoma

  2023cites this paper
• Medulloblastoma: Current Perspectives and Recent Advances

  2023cites this paper
• Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies.

  2022cites this paper
• Radiomics-based machine learning models for prediction of medulloblastoma subgroups: a systematic review and meta-analysis of the diagnostic test performance

  2022cites this paper
• Pediatric Brain Tumors in the Molecular Era: Updates for the Radiologist.

  2022cites this paper
• Whole-genome sequencing of extrachromosomal circular DNA of cerebrospinal fluid of medulloblastoma

  2022cites this paper
• A combined hypofractionated volumetric modulated arc radiotherapy, radio-sensitising and adjuvant metronomic chemotherapy treatment for canine stage IV nasal tumours with intracranial extension.

  2022cites this paper
• Pathological implications of metabolic reprogramming and its therapeutic potential in medulloblastoma

  2022cites this paper
• Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management

  2022cites this paper
• The Current State of Radiotherapy for Pediatric Brain Tumors: An Overview of Post-Radiotherapy Neurocognitive Decline and Outcomes

  2022cites this paper
• Nanomedicines and cell-based therapies for embryonal tumors of the nervous system.

  2022cites this paper
• Cross-translational models of late-onset cognitive sequelae and their treatment in pediatric brain tumor survivors.

  2022cites this paper
• Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir

  2022cites this paper
• Risk Factors for Survival in Patients With Medulloblastoma: A Systematic Review and Meta-Analysis

  2022cites this paper
• Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies

  2022cites this paper
• Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification

  2022cites this paper
• Prognostic factors related to overall survival in adolescent and young adults with medulloblastoma: A systematic review

  2022influential citation
• Clinical Trials in High-Risk Medulloblastoma: Evolution of the SIOP-Europe HR-MB Trial

  2022cites this paper
• Childhood Medulloblastoma: An Overview.

  2022cites this paper
• Safety and efficacy of concurrent carboplatin during full‐dose craniospinal irradiation for high‐risk/metastatic medulloblastoma in a resource‐limited setting

  2021cites this paper
• Temporal profiling of therapy resistance in human medulloblastoma identifies novel targetable drivers of recurrence

  2021cites this paper
• SIOP PNET5 MB Trial: History and Concept of a Molecularly Stratified Clinical Trial of Risk-Adapted Therapies for Standard-Risk Medulloblastoma

  2021cites this paper
• Radiotherapy in Medulloblastoma—Evolution of Treatment, Current Concepts and Future Perspectives

  2021cites this paper
• Current treatments of medulloblastoma

  2021cites this paper
• Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.

  2021cites this paper
• High-risk Medulloblastoma-Balancing the High Stakes of Molecular Profiling to Enhance Treatment Responsivity.

  2021cites this paper
• Management of high-risk medulloblastoma.

  2021cites this paper
• Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma

  2021cites this paper
• What does a non-response to induction chemotherapy imply in high-risk medulloblastomas?

  2021cites this paper
• Overview and recent advances in the targeting of medulloblastoma cancer stem cells

  2021cites this paper
• Adjuvant therapy for high risk medulloblastoma: More is better?

  2021cites this paper
• Circulating Lymphocyte Counts Early During Radiotherapy are Associated with Recurrence in Pediatric Medulloblastoma.

  2021cites this paper
• Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).

  2021cites this paper
• Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches

  2020cites this paper
• Strategy to minimize radiation burden in infants and high‐risk medulloblastoma using intrathecal methotrexate and high‐dose chemotherapy: A prospective registry study in Japan

  2020cites this paper
• Medulloblastoma: Molecular understanding, treatment evolution, and new developments.

  2020cites this paper
• A rapid review of evidence and recommendations from the SIOPE radiation oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises

  2020cites this paper
• Brain tumors: Medulloblastoma, ATRT, ependymoma

  2020cites this paper
• Integrating Systemic Therapy into the Management of Brain Metastases

  2020cites this paper
• Promising survival rate but high incidence of treatment‐related mortality after reduced‐dose craniospinal radiotherapy and tandem high‐dose chemotherapy in patients with high‐risk medulloblastoma

  2020cites this paper
• Phase II study of reduced‐dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium

  2020cites this paper
• How I Treat Medulloblastoma in Children

  2020cites this paper
• Survival difference between brainstem and cerebellum medulloblastoma: the surveillance, epidemiology, and end results-based study

  2020cites this paper
• Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era

  2020cites this paper
• Fusion genes as biomarkers in pediatric cancers: A review of the current state and applicability in diagnostics and personalized therapy.

  2020cites this paper
• Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase 2 trial PNET HR+5.

  2020cites this paper
• Patterns of failure in pediatric medulloblastoma and implications for hippocampal sparing

  2020cites this paper
• Medulloblastomas

  2020cites this paper
• Pediatric Cancer.

  2020cites this paper
• Improving the quality of care in the molecular era for children and adolescents with medulloblastoma

  2019cites this paper
• Medulloblastoma in the age of molecular subgroups: a review.

  2019cites this paper
• Treatment-induced remission of medulloblastoma using a chemotherapeutic regimen devoid of vincristine in a child with Charcot-Marie-Tooth disease.

  2019cites this paper
• Medulloblastoma

  2019cites this paper
• Radiotherapy Advances in Paediatric Medulloblastoma Treatment.

  2019cites this paper
• Medulloblastoma genomics in the modern molecular era

  2019cites this paper
• Central Nervous System Tumors

  2019cites this paper
• Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.

  2018cites this paper
• A Rare Extra-Axial Midline Tentorial Adult Medulloblastoma with Dural-Tail Sign Mimicking a Meningioma

  2018cites this paper